Evolution of the cardiovascular profile after renal transplantation in type 1 diabetic
ConclusionIn DT1 patients, renal transplantation is the best treatment for ESRD despite the use of corticosteroids and anticalcineurins. However, prior explorations of good cardiac function and adequate vascular compliance are essential to reduce the risk of CV.
Conclusions: the prevalence found was higher than that of other national researches, especially for the female gender. In the male gender, not having internet access, a lesser number of family members and a longer screen time proved to be factors associated with being excess weight.Resumo Objetivos: investigar a preval ência de excesso de peso e fatores associados entre adolescentes de uma comunidade de baixa renda situada na cidade do Recife, Pernambuco. Métodos: estudo transversal, em que foram coletadas informações demográficas, socioeconômicas e comportamentais no período ...
Conclusion: The present study indicates a downward secular trend in the menarcheal age of the Saudi population. Moreover, a negative correlation between BMI and menarcheal age was also documented. PMID: 31522226 [PubMed - in process]
Publication date: Available online 16 September 2019Source: The American Journal of SurgeryAuthor(s): Minyoung Kwak, J. Hunter Mehaffey, Robert B. Hawkins, Angel Hsu, Bruce Schirmer, Peter T. HallowellAbstractIntroductionObesity is a risk factor for non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC). Bariatric surgery can provide durable weight-loss, but little is known about the later development of NASH and HCC after surgery.MethodsBariatric surgery (n=3,410) and obese controls (n=46,873) from an institutional data repository were propensity score matched 1:1 by demographics, comorbidities, BMI, and ...
Condition: Multiple Myeloma Interventions: Drug: Belantamab mafodotin; Drug: Bortezomib; Drug: Lenalidomide; Drug: Dexamethasone Sponsor: GlaxoSmithKline Not yet recruiting
Conditions: Obesity; Morbid Obesity; Diabetes Mellitus, Type 2; Atrial Fibrillation Intervention: Behavioral: Intermittent Fasting Sponsor: University of Chicago Recruiting
Condition: Type 2 Diabetes Intervention: Diagnostic Test: Continuous glucose monitoring Sponsors: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; AztraZeneca Recruiting
Condition: Obesity Interventions: Behavioral: Project Health; Other: Educational Video Control Sponsor: University of Houston Not yet recruiting
Condition: Clostridium Difficile Infection Intervention: Procedure: Fecal Microbiota Transplant Sponsor: Methodist Health System Enrolling by invitation
Conditions: Pregnancy; Gestational Diabetes Intervention: Behavioral: TLC Group Prenatal Care Sponsor: Washington University School of Medicine Not yet recruiting
Condition: Diabetes Mellitus, Type 2 Intervention: Device: BD Diabetes Care Application (for mobile devices) PLUS use of BD Nano Pen Needle Sponsor: Becton, Dickinson and Company Recruiting
More News: Angiography | Angioplasty | Cardiology | Cardiovascular | Chronic Kidney Disease | Corticosteroid Therapy | Diabetes | Diabetes Type 1 | Dialysis | Endocrinology | Gangrene | Heart | Hemodialysis | Kidney Transplant | Kidney Transplantation | Obesity | Peritoneal Dialysis | Renal Failure | Study | Transplants | Urology & Nephrology